In 2014, UNAIDS committed to ambitious testing and treatment targets to end the AIDS epidemic. By 2020, 90% of all people living with HIV will know their HIV status. By 2020, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy. By 2020, 90% of all people receiving antiretroviral therapy will have viral suppression. The targets increase to 95% for testing, treatment, and viral suppression by 2030.
m2m and its Mentor Mother Model advances UNAIDS 90-90-90 and 95-95-95 targets in the following ways:
90% | 95% Diagnosed: m2m’s Mentor Mothers promote HIV testing in health facilities among pregnant women and mothers coming for health services, and in communities by encouraging mothers to have their family members tested. Mentor Mothers and adolescent Peer Mentors also encourage adolescent girls and young women to know their status and engage in safer sex practices.
90% | 95% On Treatment: m2m ensures that women testing positive for HIV receive antiretroviral therapy. For HIV-positive women receiving antenatal and postnatal care, Mentor Mothers educate them on how to take their medicine and the importance of continuing therapy after the pregnancy ends. Community Mentor Mothers, who reach women at home, check that they and other family members living with HIV have adequate supplies of antiretroviral therapy, and ensure clients receive refills if not.
90% | 95% Virally Suppressed: Mentor Mothers monitor and stay in contact with their clients so that they return to their health facilities for follow up care, viral load testing, and continued treatment. Only by increasing retention in the health care system and reducing loss to follow-up can we ensure that those on therapy will be virally suppressed.